Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Axsome Thera (AXSM)
Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,278,433
  • Shares Outstanding, K 43,573
  • Annual Sales, $ 50,040 K
  • Annual Income, $ -187,130 K
  • 60-Month Beta 1.92
  • Price/Sales 65.74
  • Price/Cash Flow N/A
  • Price/Book 29.16
Trade AXSM with:

Options Overview Details

View History
  • Implied Volatility 53.07% ( -0.39%)
  • Historical Volatility 38.35%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 238.18% on 06/13/22
  • IV Low 53.07% on 06/09/23
  • Put/Call Vol Ratio 0.55
  • Today's Volume 96
  • Volume Avg (30-Day) 1,228
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 35,544
  • Open Int (30-Day) 36,396

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -1.30
  • Number of Estimates 9
  • High Estimate -1.03
  • Low Estimate -1.54
  • Prior Year -1.06
  • Growth Rate Est. (year over year) -22.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.07 +12.88%
on 05/25/23
82.25 -7.96%
on 05/11/23
-1.03 (-1.35%)
since 05/09/23
3-Month
53.71 +40.95%
on 03/10/23
82.85 -8.62%
on 05/08/23
+13.74 (+22.17%)
since 03/09/23
52-Week
20.63 +266.97%
on 06/16/22
82.85 -8.62%
on 05/08/23
+49.69 (+190.95%)
since 06/09/22

Most Recent Stories

More News
Prediction: These 2 Stocks Could Double In the Next Year

It would be a continuation of solid recent performances.

CRSP : 61.61 (-1.57%)
AXSM : 74.88 (-0.48%)
2 Biotech Stocks That Could Help Set You Up for Life

These two promising companies have the potential to beat the market over time.

VRTX : 334.10 (+0.46%)
AXSM : 74.88 (-0.48%)
2 Bear Market Defying Stocks to Buy in May

These stocks still have plenty of market-beating years ahead.

SNY : 51.24 (-0.58%)
AXSM : 74.88 (-0.48%)
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond

Both Axsome Therapeutics and Exelixis have potentially game-changing products in their pipelines.

AXSM : 74.88 (-0.48%)
EXEL : 19.38 (+0.16%)
Is a Victory for Its Rivals Bad News for Axsome Therapeutics?

The biopharmaceutical company's shares have soared during the past year.

HLUKF : 24.6250 (+6.88%)
AXSM : 74.88 (-0.48%)
3 Growth Stocks to Buy and Hold

These three stocks defied the bear market last year.

AXSM : 74.88 (-0.48%)
LLY : 444.80 (-0.19%)
VRTX : 334.10 (+0.46%)
2 Magnificent Growth Stocks You Can Buy With $150 Right Now

You don't have to wait until you're rich to start getting your money to work for you.

COMP : 3.77 (+2.72%)
AXSM : 74.88 (-0.48%)
INMD : 33.95 (-0.47%)
Axsome's New Drug Is Scoring a Win. Is the Stock a Buy?

The biotech's share price more than doubled during last year's bear market.

JAZZ : 127.54 (-0.04%)
AXSM : 74.88 (-0.48%)
Axsome (AXSM) Q1 Earnings Beat Estimates, Auvelity Volume Rises

Axsome (AXSM) incurs a narrower-than-expected loss in 1Q23. Its revenues beat estimates and stock gains.

JAZZ : 127.54 (-0.04%)
AXSM : 74.88 (-0.48%)
ALLO : 5.78 (-0.34%)
OCUP : 3.98 (+0.51%)
Axsome Therapeutics (AXSM) Q1 2023 Earnings Call Transcript

AXSM earnings call for the period ending March 31, 2023.

AXSM : 74.88 (-0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

See More

Key Turning Points

3rd Resistance Point 78.16
2nd Resistance Point 77.43
1st Resistance Point 76.34
Last Price 74.88
1st Support Level 74.52
2nd Support Level 73.79
3rd Support Level 72.70

See More

52-Week High 82.85
Last Price 74.88
Fibonacci 61.8% 59.08
Fibonacci 50% 51.74
Fibonacci 38.2% 44.40
52-Week Low 20.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar